<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://scemsprotocols.com/scems/index.php?action=history&amp;feed=atom&amp;title=Xopenex</id>
	<title>Xopenex - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://scemsprotocols.com/scems/index.php?action=history&amp;feed=atom&amp;title=Xopenex"/>
	<link rel="alternate" type="text/html" href="https://scemsprotocols.com/scems/index.php?title=Xopenex&amp;action=history"/>
	<updated>2026-04-05T05:48:50Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.44.0</generator>
	<entry>
		<id>https://scemsprotocols.com/scems/index.php?title=Xopenex&amp;diff=1449&amp;oldid=prev</id>
		<title>Treloars: Created page with &quot;==Section 8 - MEDICATION GUIDELINES== ===BRONCHODILATORS===   ====Levalbuterol (XOPENEX) / Beta2-Adrenergic Receptor Agonist / Bronchodilator==== &#039;&#039;&#039;DESCRIPTION&#039;&#039;&#039; * Xopenex (...&quot;</title>
		<link rel="alternate" type="text/html" href="https://scemsprotocols.com/scems/index.php?title=Xopenex&amp;diff=1449&amp;oldid=prev"/>
		<updated>2020-04-24T12:43:25Z</updated>

		<summary type="html">&lt;p&gt;Created page with &amp;quot;==Section 8 - MEDICATION GUIDELINES== ===BRONCHODILATORS===   ====Levalbuterol (XOPENEX) / Beta2-Adrenergic Receptor Agonist / Bronchodilator==== &amp;#039;&amp;#039;&amp;#039;DESCRIPTION&amp;#039;&amp;#039;&amp;#039; * Xopenex (...&amp;quot;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;==Section 8 - MEDICATION GUIDELINES==&lt;br /&gt;
===BRONCHODILATORS===&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
====Levalbuterol (XOPENEX) / Beta2-Adrenergic Receptor Agonist / Bronchodilator====&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;DESCRIPTION&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* Xopenex (levalbuterol HCl) Inhalation Solution is a sterile, clear, colorless, preservative-free solution of the hydrochloride salt of levalbuterol, the (R)-enantiomer of the drug substance racemic albuterol. Levalbuterol HCl is a relatively selective beta2-adrenergic receptor agonist&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;INDICATIONS&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* For the treatment of bronchospasm associated with [[Acute Asthma or COPD with Wheezing|asthma or COPD with wheezing]].&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;CONTRAINDICATIONS&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* Xopenex (levalbuterol HCl) Inhalation Solution is contraindicated in patients with a history of hypersensitivity to levalbuterol HCl or racemic albuterol.&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;PRECAUTIONS&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* Levalbuterol HCl, like all sympathomimetic amines, should be used with caution in patients with cardiovascular disorders, especially coronary insufficiency, hypertension, and cardiac arrhythmias; in patients with convulsive disorders, hyperthyroidism, or diabetes mellitus; and in patients who are unusually responsive to sympathomimetic amines.&lt;br /&gt;
* Use with Beta-blockers, diuretics, Digoxin, antihistamines or tricyclic antidepressants may cause adverse cardiac effects.&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;DOSAGE&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* Adults: 1.25 mg nebulized via updraft&lt;br /&gt;
* Pediatrics: refer to Handtevy System&lt;br /&gt;
** Less than 6 years of age: 0.31 mg nebulized via updraft added to 2.5 ml of normal saline&lt;br /&gt;
** 6 years and older: 0.63 mg nebulized via updraft added to 2.5 ml of normal saline&lt;br /&gt;
&lt;br /&gt;
[[Category:Medication Guidelines|Xopenex]]&lt;/div&gt;</summary>
		<author><name>Treloars</name></author>
	</entry>
</feed>